Vaccine Trials Seen Resuming; Cases Top 41 Million: Virus Update

(Bloomberg) -- The U.S. trials of coronavirus vaccines made by AstraZeneca Plc and Johnson & Johnson may resume as soon as next week, according to the head of the Operation Warp Speed program. A pa...